Study Title
ACNS1422: A phase 2 study of reduced therapy for newly diagnosed average-risk WNT-driven medulloblastoma patients
Protocol ID
ACNS1422
Condition/s
Medulloblastoma
Diagnosis Stage
New diagnosis
Location
NSW, WA, SA
Sponsor
Children's Oncology Group
Collaborators
National Cancer Institute (NCI)
Links
Trial Status
Open
Sites
Perth Children's Hospital
Women's & Children's Hospital
The Children's Hospital at Westmead
Women's & Children's Hospital
The Children's Hospital at Westmead
Study Type
Treatment
Phase
Phase 2
Age Eligibility
3 years to 22 years at the time of enrollment
International registry ID's
NCT02724579
| Study Title | ACNS1422: A phase 2 study of reduced therapy for newly diagnosed average-risk WNT-driven medulloblastoma patients |
|---|---|
| Protocol ID | ACNS1422 |
| Disease (Sub Disease) | Medulloblastoma |
| Diagnosis Stage | New diagnosis |
| Location | NSW / WA / SA |
| Sponsor | Children's Oncology Group |
| Collaborators | National Cancer Institute (NCI) |
| Links | https://clinicaltrials.gov/ct2/show/NCT02724579 |
| Trial Status | Open |
| Sites | Perth Children's Hospital / Women's & Children's Hospital/ The Children's Hospital at Westmead/ |
| Study Type | Treatment |
| Phase | Phase 2 |
| Age Eligibility | 3 years to 22 years at the time of enrollment |
| International registry ID's | NCT02724579 |